C. Pisano

发表

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells

G. Botti, P. Ascierto, S. Pignata, 2005, Cancer Immunology, Immunotherapy.

Time without symptoms or toxicity (TWiST) in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib or placebo plus bevacizumab: Analysis of PAOLA-1/ENGOT-ov25 phase III trial.

K. Yonemori, I. Vergote, I. Ray-Coquard, 2022, Journal of Clinical Oncology.

Obesity and Cancer: Biological Links and Treatment Implications.

S. Pignata, A. Avallone, S. Tafuto, 2017, Current cancer drug targets.